Titus Benjamin Ball, an officer of BeOne Medicines Ltd., filed a Form 144 notice of proposed sale of 1,559 American Depositary Shares on November 6, 2026, with the securities to be sold on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services.

Key Highlights

  • Proposed sale: 1,559 ADS with an aggregate market value of $632,277.24, according to the filing.
  • Acquisition method: The shares were acquired on November 6, 2026, through the exercise of options under a registered plan, with the issuer listed as the person from whom acquired.
  • Payment: The filing states the nature of payment was cash, made on November 6, 2026.
  • Shares outstanding: The filing reports 58,926,111 ADS outstanding at the time of filing.
  • Prior sales: Ball sold 132 ADS on September 1, 2026, for gross proceeds of $46,973.52, as disclosed in the past three months' sales section.
  • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004, is named as the broker for the proposed sale.

BeOne Medicines Officer Proposes ADS Sale Following Option Exercise

According to the Form 144 filing dated November 6, 2026, Titus Benjamin Ball, identified as an officer of BeOne Medicines Ltd. (NASDAQ:ONC as listed on the filing is not confirmed; the filing names the exchange as NASDAQ without a ticker symbol), filed a notice of proposed sale of 1,559 ADS in BeOne Medicines Ltd. The aggregate market value of the proposed sale was listed as $632,277.24. The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services as the named broker for the transaction.

The filing discloses that the 1,559 ADS were acquired on November 6, 2026, through the exercise of options under a registered plan, with the issuer named as the party from whom the securities were acquired. Cash was listed as the nature of payment, also on November 6, 2026. The approximate date of sale is listed as November 6, 2026. BeOne Medicines Ltd. is listed with an issuer address of 94 Solaris Avenue, Camana Bay, Grand Cayman, Cayman Islands, and an SEC file number of 001-37686.

The filing also discloses that Ball sold 132 ADS on September 1, 2026, generating gross proceeds of $46,973.52, which falls within the three-month look-back period required by Rule 144. The filing was signed by Titus B. Ball, and the notice date is recorded as November 6, 2026. The total number of ADS outstanding is reported as 58,926,111 in the filing.

What Was Disclosed

BeOne Medicines Ltd. officer Titus Benjamin Ball filed a Form 144 notice proposing to sell 1,559 ADS, valued at $632,277.24, acquired via option exercise on November 6, 2026. A prior sale of 132 ADS on September 1, 2026, was also disclosed.